FEATURE ARTICLES
Restrictions and fear on the Hormuz Strait have fractured supply chains, especially for primary materials used in pharmaceutical packaging.
- May 2026 — CDMO Opportunities And Threats Report
- Can Molecular Glue Degraders Make The Undruggable Druggable?
- Use Of AI In FDA Inspection Activities: Strategies For Effective Preparation
- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
- Managing Organic Impurities And Nitrosamines In APIs
- Chugai Accelerates Automation To Boost Operational Efficiency
- The Future Of Continuous Is Integrated Manufacturing: The 4 Misconceptions About A Lean Process
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-2215842261-lab-scientist-looking-down-research]( "A Guide To Process Transparency In Custom Lab Automation Development")
A Guide To Process Transparency In Custom Lab Automation DevelopmentDiscover a practical guide to building custom automation systems with clarity and confidence, as well as how transparent processes reduce risk, prevent misalignment, and support reliable testing.
-
The Role Of Processing And Supplier Diversification5/26/2026
Optimizing UHMWPE implants requires balancing materials, processing, and sourcing to improve performance, reduce risk, and lower costs in medical device manufacturing.
-
Leveraging Integrated Electronic Laboratory Notebook And Inventory Systems6/15/2026
Integrating lab notebooks with inventory and asset tracking boosts accuracy and traceability. Real-time visibility cuts errors, speeds decisions, and supports compliant, scalable pharma development.
-
Reducing Costs & Risks: A Pharma Guide To FTZ Subzones For U.S. Drug Manufacturing2/11/2025
Utilized wisely, FTZs and subzones can be tools for cost savings and can enable pharma companies to leverage the benefits of American manufacturing.
-
5 Steps To Design A Microbiological Performance Qualification For Facilities4/21/2025
Explore five steps to design an EMPQ for sterile manufacturing: classification, protocol drafting, cleaning evaluation, disinfectant efficacy testing, and continuous improvement.
-
Why A Paperless Approach Is A Non-Negotiable In CQV6/9/2026
Regulatory expectations are forcing a shift away from paper-based validation toward digital systems that enable faster execution, stronger oversight, and more reliable, audit-ready CQV processes.
PHARMA ONLINE APP NOTES & CASE STUDIES
- 3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons
- Single Unit Dose Nasal Spray Carton Provides Cost Savings
- The Value Of Peptones For Enhancing Biopharmaceutical Productivity
- How LIMS Supports QC Scaling At Forge Biologics
- Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator System
NEWSLETTER ARCHIVE
- 06.19.26 -- The Future Of Continuous Is Integrated Manufacturing: The 4 Misconceptions About A Lean Process
- 06.18.26 -- STREAM Edition: Answering The Demand And Innovation
- 06.17.26 -- Reduce mAb Aggregates: Practical Strategies
- 06.16.26 -- Why FAT Should Confirm Alignment, Not Reveal Its Absence
- 06.16.26 -- Environmental Monitoring For GMP
INDUSTRY NEWS
-
![white coupon banner, great topic-GettyImages-2271702407]( "Let Your Voice Help Shape Pharma Manufacturing")
Let Your Voice Help Shape Pharma ManufacturingPharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
![rating service, satisfaction-GettyImages-2221603596]( "ISPE Announces 2026 FOYA Winners")
ISPE Announces 2026 FOYA WinnersThese awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Recipharm Invests In U.S. Fill-Finish Infrastructure To Accelerate Biologics Development6/17/2026
Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announced a multi-million-dollar investment in its US operations, strengthening its ability to support pharmaceutical and biotechnology companies with advanced sterile fill and finish services for biologics and advanced therapies.
-
Four Myths About Embedded CMOs, Busted6/17/2026
If you’re looking for a contract manufacturer to bring your therapy to market, you’re far from alone. Demand for manufacturing services is shaping the pharma Contract Manufacturing Industry, with analysts predicting a growth rate of nearly 7% per year until 2028.
-
Avoiding Recalls: How To Ensure Sterility In Ophthalmic Products6/17/2026
In the wake of several high-profile eye drop recalls, we look at the challenges of achieving sterility in ophthalmic products, the consequences of failing to do so, and how AbbVie Contract Manufacturing ensures product sterility and safety.
-
Veranova Appoints Dr. Bob Huang Vice President And General Manager Of West Deptford Site6/3/2026
Veranova today announced the appointment of Dr. Bob Huang as Vice President and General Manager for its West Deptford, New Jersey facility. He will lead site operations, advance strategic growth initiatives, and strengthen manufacturing excellence and customer delivery.
